Skip to main content
logo
Abbott Laboratories (FRA:ABL)
Germany flag Germany · Delayed Price · Currency is EUR
89.51
+0.64 (0.72%)
At close: Jan 30, 2026

Abbott Laboratories Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-13,4025,7236,9337,071
Depreciation & Amortization
-3,2183,2433,2673,538
Loss (Gain) From Sale of Assets
-48212621555
Stock-Based Compensation
-673644685640
Change in Accounts Receivable
--691-356-68-383
Change in Inventory
--58-232-1,413-456
Change in Accounts Payable
-356-7604201,288
Change in Income Taxes
--8,028-585-383-908
Change in Other Net Operating Assets
--796-542-75-312
Operating Cash Flow
-8,5587,2619,58110,533
Operating Cash Flow Growth
-17.86%-24.21%-9.04%33.31%
Capital Expenditures
--2,207-2,202-1,777-1,885
Cash Acquisitions
---877--187
Divestitures
-14048134
Investment in Securities
--141-116-33-96
Other Investing Activities
-9222226
Investing Cash Flow
--2,338-3,133-1,740-2,008
Short-Term Debt Issued
--2147-
Long-Term Debt Issued
-223274
Total Debt Issued
-22323544
Short-Term Debt Repaid
--100---204
Long-Term Debt Repaid
--660-2,498-753-48
Total Debt Repaid
--760-2,498-753-252
Net Debt Issued (Repaid)
--537-2,475-699-248
Issuance of Common Stock
-264167167255
Repurchase of Common Stock
--1,295-1,227-3,795-2,299
Common Dividends Paid
--3,836-3,556-3,309-3,202
Financing Cash Flow
--5,404-7,091-7,636-5,494
Foreign Exchange Rate Adjustments
--96-23-122-70
Net Cash Flow
-720-2,986832,961
Free Cash Flow
-6,3515,0597,8048,648
Free Cash Flow Growth
-25.54%-35.17%-9.76%51.08%
Free Cash Flow Margin
-15.14%12.61%17.88%20.08%
Free Cash Flow Per Share
-3.632.894.424.83
Cash Interest Paid
-604662563544
Cash Income Tax Paid
-1,7231,4751,8641,941
Levered Free Cash Flow
-5,6104,9907,3407,675
Unlevered Free Cash Flow
-5,9595,3897,6898,009
Change in Working Capital
--9,217-2,475-1,519-771
Source: S&P Global Market Intelligence. Standard template. Financial Sources.